OOIR: Observatory of International Research

Papers

(The median citation count of Influenza and Other Respiratory Viruses is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Medical masks vs N95 respirators for preventing COVID‐19 in healthcare workers: A systematic review and meta‐analysis of randomized trials	325
COVID‐19 transmission through asymptomatic carriers is a challenge to containment	206
COVID‐19: Face masks and human‐to‐human transmission	132
COVID‐19 vaccine hesitancy and attitudes in Qatar: A national cross‐sectional survey of a migrant‐majority population	110
Increased risk of rhinovirus infection in children during the coronavirus disease‐19 pandemic	93
Influenza and COVID‐19: What does co‐existence mean?	73
Respiratory syncytial virus disease burden in adults aged 60 years and older in high‐income countries: A systematic literature review and meta‐analysis	63
SARS‐CoV‐2 environmental contamination associated with persistently infected COVID‐19 patients	60
COVID‐19 severity from Omicron and Delta SARS‐CoV‐2 variants	56
Uncertainties about the transmission routes of 2019 novel coronavirus	56
Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID‐19) from Zhejiang province in China	50
Differential COVID‐19 case positivity in New York City neighborhoods: Socioeconomic factors and mobility	50
Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis	49
Which influenza viruses will emerge following the SARS‐CoV‐2 pandemic?	47
Evidence for pre‐symptomatic transmission of coronavirus disease 2019 (COVID‐19) in China	47
Human respiratory syncytial virus and influenza seasonality patterns—Early findings from the WHO global respiratory syncytial virus surveillance	47
Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID‐19 pandemic	45
Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries	39
Admission respiratory status predicts mortality in COVID‐19	37
Sixty‐eight consecutive patients assessed for COVID‐19 infection: Experience from a UK Regional infectious diseases Unit	36
The economic burden of influenza among adults aged 18 to 64: A systematic literature review	34
The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review	33
Population anxiety and positive behaviour change during the COVID‐19 epidemic: Cross‐sectional surveys in Singapore, China and Italy	33
International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: Association with school closures	32
The impact of the 2009 influenza pandemic on the seasonality of human respiratory syncytial virus: A systematic analysis	30

Associations between persistent symptoms after mild COVID‐19 and long‐term health status, quality of life, and psychological distress	29
Impact of coronavirus disease 2019 on respiratory surveillance and explanation of high detection rate of human rhinovirus during the pandemic in the Republic of Korea	24
Severity and mortality of respiratory syncytial virus vs influenza A infection in hospitalized adults in China	23
Healthcare workers in Singapore infected with COVID‐19: 23 January‐17 April 2020	23
Re‐emergence of influenza virus circulation during 2020 in parts of tropical Asia: Implications for other countries	22
Using the health belief model to identify barriers to seasonal influenza vaccination among Australian adults in 2019	22
Transmission of SARS‐CoV‐2 during a 2‐h domestic flight to Okinawa, Japan, March 2020	22
Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017–2019	21
Household transmission of COVID‐19 among the earliest cases in Antananarivo, Madagascar	20
Adenovirus infection in children hospitalized with pneumonia in Guangzhou, China	20
Impact of varying wave periods of COVID‐19 on in‐hospital mortality and length of stay for admission through emergency department: A territory‐wide observational cohort study	20
The COVID‐19 epidemic in Madagascar: clinical description and laboratory results of the first wave, march‐september 2020	19
Population‐based assessment of risks for severe COVID‐19 disease outcomes	18
Absence of association between 2019‐20 influenza vaccination and COVID‐19: Results of the European I‐MOVE‐COVID‐19 primary care project, March‐August 2020	18
Comprehensive assessment of amino acid substitutions in the trimeric RNA polymerase complex of influenza A virus detected in clinical trials of baloxavir marboxil	17
The burden of seasonal influenza in Italy: A systematic review of influenza‐related complications, hospitalizations, and mortality	17
The role of non‐pharmaceutical interventions on influenza circulation during the COVID‐19 pandemic in nine tropical Asian countries	17
Factors associated with COVID‐19 related hospitalisation, critical care admission and mortality using linked primary and secondary care data	17
Risk factors for outbreaks of COVID‐19 in care homes following hospital discharge: A national cohort analysis	16
Epidemiology of respiratory viruses in patients with severe acute respiratory infections and influenza‐like illness in Suriname	16
Estimating the burden of adult hospital admissions due to RSV and other respiratory pathogens in England	16
Asymptomatic transmission of SARS‐CoV‐2 and implications for mass gatherings	16
Epidemiology and burden of illness of seasonal influenza among the elderly in Japan: A systematic literature review and vaccine effectiveness meta‐analysis	16
Symptoms and recovery among adult outpatients with and without COVID‐19 at 11 healthcare facilities—July 2020, United States	16
Epidemiological and clinical features of SARS‐CoV‐2 infection in children during the outbreak of Omicron variant in Shanghai, March 7–31, 2022	15
Pre‐symptomatic transmission of novel coronavirus in community settings	15
Clinical manifestations of COVID‐19 differ by age and obesity status	15
ROSES‐S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS‐CoV‐2	15
Differentiating impacts of non‐pharmaceutical interventions on non‐coronavirus disease‐2019 respiratory viral infections: Hospital‐based retrospective observational study in Taiwan	14
Diagnostic performance of COVID‐19 serological assays during early infection: A systematic review and meta‐analysis of 11 516 samples	14
A Sanger sequencing protocol for SARS‐CoV‐2 S‐gene	14
Viral epidemiology and SARS‐CoV‐2 co‐infections with other respiratory viruses during the first COVID‐19 wave in Paris, France	13
Home collection of nasal swabs for detection of influenza in the Household Influenza Vaccine Evaluation Study	13
Novel and extendable genotyping system for human respiratory syncytial virus based on whole‐genome sequence analysis	13
Antibody responses to COVID‐19 vaccination in people with obesity: A systematic review and meta‐analysis	13
Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness	13
Delayed respiratory syncytial virus outbreak in 2020 in Taiwan was correlated with two novel RSV‐A genotype ON1 variants	13
Risk of symptomatic COVID‐19 due to aircraft transmission: a retrospective cohort study of contact‐traced flights during England’s containment phase	13
A six‐plex droplet digital RT‐PCR assay for seasonal influenza virus typing, subtyping, and lineage determination	13
Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post‐discharge assessed by Respiratory Intensity a	13
Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults	13
Oseltamivir treatment of influenza A and B infections in infants	12
Cohort profile: A Prospective Household cohort study of Influenza, Respiratory syncytial virus and other respiratory pathogens community burden and Transmission dynamics in South Africa, 2016–2018	12
Characterization of community‐wide transmission of SARS‐CoV‐2 in congregate living settings and local public health‐coordinated response during the initial phase of the COVID‐19 pandemic	12
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study	12
Severe acute respiratory syndrome coronavirus 2 can be detected in exhaled aerosol sampled during a few minutes of breathing or coughing	12
Etiologies of severe acute respiratory infection (SARI) and misdiagnosis of influenza in Indonesia, 2013‐2016	12
Upsurge of human rhinovirus infection followed by a delayed seasonal respiratory syncytial virus infection in Thai children during the coronavirus pandemic	12
Epidemiological analysis of the first 1000 cases of SARS‐CoV‐2 lineage BA.1 (B.1.1.529, Omicron) compared with co‐circulating Delta in Wales, UK	12
COVID‐19 outbreaks in aged‐care facilities in Australia	11

Global patterns of seasonal influenza activity, duration of activity and virus (sub)type circulation from 2010 to 2020	11
Population‐based hospitalization burden estimates for respiratory viruses, 2015–2019	11
Record high parainfluenza season in children after relaxation of COVID‐19 restrictions in fall 2021—A nationwide register study in Finland	11
Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand	11
Clinical characteristics and population‐based attack rates of respiratory syncytial virus versus influenza hospitalizations among adults—An observational study	11
Seasonal influenza in children: Costs for the health system and society in Europe	11
Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study	11
Incidence of influenza virus infections confirmed by serology in children and adult in a suburb community, northern China, 2018‐2019 influenza season	11
Respiratory syncytial virus seasonality in three epidemiological zones of Kenya	11
Interactions among common non‐SARS‐CoV‐2 respiratory viruses and influence of the COVID‐19 pandemic on their circulation in New York City	11
Epidemiological and clinical characteristics of respiratory syncytial virus and influenza infections in hospitalized children before and during the COVID‐19 pandemic in Central China	10
All‐cause versus cause‐specific excess deaths for estimating influenza‐associated mortality in Denmark, Spain, and the United States	10
Determining the seasonality of respiratory syncytial virus in Slovenia	10
Changes in virus detection in hospitalized children before and after the severe acute respiratory syndrome coronavirus 2 pandemic	10
Age‐related risk of household transmission of COVID‐19 in Singapore	10
Epidemiology of acute lower respiratory tract infection hospitalizations in Thai children: A 5‐year national data analysis	10
Health‐seeking behaviors of patients with acute respiratory infections during the outbreak of novel coronavirus disease 2019 in Wuhan, China	10
Respiratory viral coinfection in a birth cohort of infants in rural Nepal	10
Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic	10
The REinfection in COVID‐19 Estimation of Risk (RECOVER) study: Reinfection and serology dynamics in a cohort of Canadian healthcare workers	10
Predictors of all‐cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS‐CoV‐2	9
The importance of influenza vaccination during the COVID‐19 pandemic	9
Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022	9
Intravenous peramivir vs oral oseltamivir in high‐risk emergency department patients with influenza: Results from a pilot randomized controlled study	9
Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trial	9
Characterization of human respiratory syncytial virus (RSV) isolated from HIV‐exposed‐uninfected and HIV‐unexposed infants in South Africa during 2015‐2017	9
Factors associated with early uptake of COVID‐19 vaccination among healthcare workers in Azerbaijan, 2021	9
Determination of respiratory syncytial virus epidemic seasons by using 95% confidence interval of positivity rates, 2011–2021, Germany	9
Household transmission of SARS‐CoV‐2 during the Omicron wave in Shanghai, China: A case‐ascertained study	9
One benefit of COVID‐19 measures in Taiwan: The reduction of influenza infections and severe complications	9
Comparative incidence and burden of respiratory viruses associated with hospitalization in adults in New York City	9
Impact of respiratory syncytial virus disease on quality of life in adults aged ≥50 years: A qualitative patient experience cross‐sectional study	9
Burden and severity of children's hospitalizations by respiratory syncytial virus in Portugal, 2015–2018	9
Prevalence and seasonality of viral respiratory infections in a temperate climate region: A 24‐year study (1997–2020)	9
Respiratory syncytial virus in pediatric influenza‐like illness cases in Lombardy, Northern Italy, during seven consecutive winter seasons (from 2014–2015 to 2020–2021)	9
Live SARS‐CoV‐2 is difficult to detect in patient aerosols	8
Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision‐making and communication	8
Predictors of influenza severity among hospitalized adults with laboratory confirmed influenza: Analysis of nine influenza seasons from the Valencia region, Spain	8
Modelling the influenza disease burden in people aged 50–64 and ≥65 years in Australia	8
Role of age and birth month in infants hospitalized with RSV‐confirmed disease in the Valencia Region, Spain	8
Some characteristics of clinical sequelae of COVID‐19 survivors from Wuhan, China: A multi‐center longitudinal study	8
National seroepidemiological study of COVID‐19 after the initial rollout of vaccines: Before and at the peak of the Omicron‐dominant period in Japan	8
Burden of respiratory viral infection in persons with human immunodeficiency virus	8
Zanamivir aqueous solution in severe influenza: A global Compassionate Use Program, 2009–2019	8
Independent association between meteorological factors, PM2.5, and seasonal influenza activity in Hangzhou, Zhejiang province, China	8
Epidemiology of SARS‐CoV‐2 infection and SARS‐CoV‐2 positive hospital admissions among children in South Africa	8
The effect of nirmatrelvir‐ritonavir on viral clearance and length of hospital stay in patients infected with SARS‐CoV‐2 omicron variants	8
Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID‐19 cases treated with sotrovimab in the community in England	7
Respiratory viruses in pediatric emergency department patients and their family members	7
Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022	7
Acute respiratory infection emergency access in a tertiary care children hospital in Italy, prior and after the SARS‐CoV‐2 emergence	7
A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom	7
Estimating the burden of influenza‐related and associated hospitalizations and deaths in France: An eight‐season data study, 2010–2018	7
Horses for courses? Assessing the potential value of a surrogate, point‐of‐care test for SARS‐CoV‐2 epidemic control	7
Relative timing of respiratory syncytial virus epidemics in summer 2021 across the United States was similar to a typical winter season	7
Molecular epidemiology of Enteroviruses and Rhinoviruses in patients with acute respiratory infections in Yaounde, Cameroon	7
Epidemiological trends in notified influenza cases in Australia’s Northern Territory, 2007‐2016	7
Epidemiological and clinical characteristics of community‐acquired and nosocomial influenza cases and risk factors associated with complications: A four season analysis of all adult patients admitted	7
Implications of the unexpected persistence of human rhinovirus/enterovirus during the COVID‐19 pandemic in Canada	7
Clinical significance of SARS‐CoV‐2‐specific IgG detection with a rapid antibody kit for COVID‐19 patients	7
Cumulative incidence of post‐infection asthma or wheezing among young children clinically diagnosed with respiratory syncytial virus infection in the United States: A retrospective database analysis	7
Human respiratory syncytial virus diversity and epidemiology among patients hospitalized with severe respiratory illness in South Africa, 2012–2015	7
Effect of COVID‐19 vaccine on menstrual experience among females in six Arab countries: A cross sectional study	6
Severe and moderate seasonal influenza epidemics among Italian healthcare workers: A comparison of the excess of absenteeism	6
Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022	6
Prevalence of antibodies against SARS‐CoV‐2 in the Norwegian population, August 2021	6
The Oregon Child Absenteeism Due to Respiratory Disease Study (ORCHARDS): Rationale, objectives, and design	6
Association between COVID‐19 and consistent mask wearing during contact with others outside the household—A nested case–control analysis, November 2020–October 2021	6
Behavioral factors associated with SARS‐CoV‐2 infection in Japan	6
Recent influenza activity in tropical Puerto Rico has become synchronized with mainland US	6
Surveillance of medically‐attended influenza in elderly patients from Romania—data from three consecutive influenza seasons (2015/16, 2016/17, and 2017/18)	6
A COVID‐19 human viral challenge model. Learning from experience	6
Prospective cohort study of influenza vaccine effectiveness among healthcare personnel in Lima, Peru: Estudio Vacuna de Influenza Peru, 2016‐2018	6
Public health and social measures during health emergencies such as the COVID‐19 pandemic: An initial framework to conceptualize and classify measures	6
Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 2022	6
Pronounced antibody elevation after SARS‐CoV‐2 BNT162b2 mRNA booster vaccination in nursing home residents	6
Estimating SARS‐CoV‐2 transmission in educational settings: A retrospective cohort study	6
Burden of influenza during the first year of life	6
Persistence of racial/ethnic and socioeconomic status disparities among non‐institutionalized patients hospitalized with COVID‐19 in Connecticut, July to December 2020	6
Influenza hospitalizations in Australian children 2010–2019: The impact of medical comorbidities on outcomes, vaccine coverage, and effectiveness	6

Epidemiology and outcome of influenza‐associated infections among hospitalized patients with acute respiratory infections, Egypt national surveillance system, 2016‐2019	6
Consistency of self‐reported and documented historical influenza vaccination status of US healthcare workers	6
mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021	6
Systematic literature review of the signs and symptoms of respiratory syncytial virus	6
Respiratory syncytial virus‐associated acute respiratory illness in adult non‐immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment	6
Attitudes, beliefs and practice of Egyptian healthcare workers towards seasonal influenza vaccination	6
Analysis of a city‐wide COVID‐19 prevention strategy for aged‐care facilities during third and fifth waves of COVID‐19 in Kyoto City, Kyoto, Japan	5
The national burden of influenza‐like illness and severe respiratory illness overall and associated with nine respiratory viruses in South Africa, 2013–2015	5
Epidemiology and seasonality of human parainfluenza serotypes 1‐3 in Australian children	5
The association between influenza infections in primary care and intensive care admissions for severe acute respiratory infection (SARI): A modelling approach	5
Estimating the serial intervals of SARS‐CoV‐2 Omicron BA.4, BA.5, and BA.2.12.1 variants in Hong Kong	5
Genomic surveillance of SARS‐CoV‐2 strains circulating in Iran during six waves of the pandemic	5
Occurrence and disease burden of respiratory syncytial virus and other respiratory pathogens in adults aged ≥65 years in community: A prospective cohort study in Japan	5
Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan	5
Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry	5
Respiratory syncytial virus and other respiratory virus infections in residents of homeless shelters – King County, Washington, 2019–2021	5
Applying the moving epidemic method to determine influenza epidemic and intensity thresholds using influenza‐like illness surveillance data 2009‐2018 in Tunisia	5
A remote household‐based approach to influenza self‐testing and antiviral treatment	5
SERS‐based immunomagnetic bead for rapid detection of H5N1 influenza virus	5
Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016‐17	5
Change in patterns of hospitalization for influenza during COVID‐19 surges	5
Using serological measures to estimate influenza incidence in the presence of secular trends in exposure and immuno‐modulation of antibody response	5
No evidence for HPAI H5N1 2.3.4.4b incursion into Australia in 2022	5
Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season	5
Incidence of SARS‐CoV‐2 infection among COVID‐19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January–September 20	5
Impact of respiratory viral infections on mortality and critical illness among hospitalized patients with chronic obstructive pulmonary disease	5
Clinical impact of rapid influenza PCR in the adult emergency department on patient management, ED length of stay, and nosocomial infection rate	5
Viral replication dynamics could critically modulate vaccine effectiveness and should be accounted for when assessing new SARS‐CoV‐2 variants	5
Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults	5
Anti‐SARS‐CoV‐2 IgG antibody levels among Thai healthcare providers receiving homologous and heterologous COVID‐19 vaccination regimens	5
A Retrospective observational cohort study of the effect of antenatal influenza vaccination on birth outcomes in Cape Town, South Africa, 2015‐2016	5
Cepheid Xpert^® Flu/RSV and Seegene Allplex^™ RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice	5
Prior SARS‐CoV‐2 infection and COVID‐19 vaccine effectiveness against outpatient illness during widespread circulation of SARS‐CoV‐2 Omicron variant, US Flu VE network	5
Neurological complications associated with influenza in hospitalized children	5
A mixed methods study of seasonal influenza vaccine hesitancy in adults with chronic respiratory conditions	5
SARS‐CoV‐2 infections in households in a peri‐urban community of Lima, Peru: A prospective cohort study	5
Unusual late epidemic peak during influenza season 2021–2022: A nationwide register‐based analysis in Finland	5
The association between early country‐level COVID‐19 testing capacity and later COVID‐19 mortality outcomes	5
The antiviral effects of baloxavir marboxil against influenza A virus infection in ferrets	5
Transmission of SARS‐CoV‐2 in standardised first few X cases and household transmission investigations: A systematic review and meta‐analysis	4
Prevalence of chronic conditions and influenza vaccination coverage rates in Germany: Results of a health insurance claims data analysis	4
Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients	4
Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected cases	4
Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system	4
Costs of seasonal influenza vaccination in South Africa	4
The accuracy of reverse genetics systems for SARS‐CoV‐2: Circular polymerase extension reaction versus bacterial artificial chromosome	4
Lower cognitive scores among toddlers in birth cohorts with acute respiratory illnesses, fevers, and laboratory‐confirmed influenza	4
Developing a sampling methodology for timely reporting of population‐based COVID‐19‐associated hospitalization surveillance in the United States, COVID‐NET 2020–2021	4
	4
Influenza surveillance systems using traditional and alternative sources of data: A scoping review	4
Are twindemics occurring?	4
Community predictors of COVID‐19 cases and deaths in Massachusetts: Evaluating changes over time using geospatially refined data	4
Seasonal respiratory virus circulation was diminished during the COVID‐19 pandemic	4
Inactivated pandemic 2009 H1N1 influenza A virus human vaccines have different efficacy after homologous challenge in the ferret model	4
Low prevalence of seasonal influenza viruses in Hong Kong, 2022	4
Incidence and seasonality of respiratory viruses among medically attended children with acute respiratory infections in an Ecuador birth cohort, 2011–2014	4
Real‐time surveillance systems: Applicability for the control of influenza in acute care	4
Incidence, circulation, and spatiotemporal analysis of seasonal influenza in Shandong, China, 2008–2019: A retrospective study	4
Influenza surveillance capacity improvements in Africa during 2011‐2017	4
Clinical phase II and III studies of an AS03‐adjuvanted H5N1 influenza vaccine produced in an EB66^® cell culture platform	4
Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011‐2016	4
Underlying cardiopulmonary conditions as a risk factor for influenza and respiratory syncytial virus infection among community‐dwelling adults aged ≥ 65 years in Thailand: Findings from a two‐year pro	4
Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months	4
Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017	4
Comparative analysis of COVID‐19 case fatality rate between two waves in Nepal	3
SARS‐CoV‐2 re‐infection versus prolonged shedding: A case series	3
Point‐of‐care testing for influenza in a university emergency department: A prospective study	3
Human post‐infection serological response to the spike and nucleocapsid proteins of SARS‐CoV‐2	3
Factors affecting the transmission of SARS‐CoV‐2 in school settings	3
Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project	3
Investigating the effects of population density of residence and rural/urban classification on rate of influenza‐like illness symptoms in England and Wales	3
	3
Influenza response planning for the centers of excellence for influenza research and surveillance: Science preparedness for enhancing global health security	3
Influenza vaccine and subsequent development of zoster	3
SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022	3
Down memory lane: Unprecedented strong public and scientific interest in the “Spanish flu” 1918/1919 during the COVID‐19 pandemic	3
First human infection of avian influenza A(H5N6) virus reported in Lao People's Democratic Republic, February–March 2021	3
BNT162b2 vaccination reduced infections and transmission in a COVID‐19 outbreak in a nursing home in Germany, 2021	3
Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands	3
Clinical and socioeconomic burden of rhinoviruses/enteroviruses in the community	3
Results from a test‐and‐treat study for influenza among residents of homeless shelters in King County, WA: A stepped‐wedge cluster‐randomized trial	3
Multi‐decade national cohort identifies adverse pregnancy and birth outcomes associated with acute respiratory illness hospitalisations during the influenza season	3
Functional outcomes in elderly patients with hospitalized COVID‐19 pneumonia: A 1 year follow‐up study	3
Seroprevalence of H7N9 infection among humans: A systematic review and meta‐analysis	3
A review of policies and coverage of seasonal influenza vaccination programs in the WHO Eastern Mediterranean Region	3
Susceptibility of different cell lines to the novel canine coronavirus CCoV‐HuPn‐2018	3
Influenza hospitalizations during childhood in children born preterm	3
Domination of influenza vaccine virus strains in Hong Kong, 2021	3
Vaccine effectiveness against COVID‐19 among symptomatic persons aged ≥12 years with reported contact with COVID‐19 cases, February–September 2021	3
SARS‐CoV‐2 infection‐induced immunity and the duration of viral shedding: Results from a Nicaraguan household cohort study	3
The burden of non‐SARS‐CoV2 viral lower respiratory tract infections in hospitalized children in Barcelona (Spain): A long‐term, clinical, epidemiologic and economic study	3
Viral etiology of life‐threatening pediatric pneumonia: A matched case‐control study	3
Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/16	3
	3
Active surveillance documents rates of clinical care seeking due to respiratory illness	3